sulfinpyrazone has been researched along with Rheumatic Heart Disease in 6 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Rheumatic Heart Disease: Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with mitral valve prolapse, TE appears to occur very infrequently." | 1.26 | Platelet survival time and thromboembolism in patients with mitral valve prolapse. ( Rainwater, J; Steele, P; Vogel, R; Weily, H, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabris, F | 1 |
| Casonato, A | 1 |
| Randi, ML | 1 |
| Schivazappa, L | 1 |
| Schiavinato, L | 1 |
| Girolami, A | 1 |
| Ludlam, CA | 1 |
| Allan, N | 1 |
| Blandford, RB | 1 |
| Dowdle, R | 1 |
| Bentley, NJ | 1 |
| Bloom, AL | 1 |
| Steele, P | 2 |
| Rainwater, J | 2 |
| Weily, H | 1 |
| Vogel, R | 1 |
| Douglas, AS | 1 |
| Steele, PP | 1 |
| Weily, HS | 1 |
| Davies, H | 1 |
| Genton, E | 1 |
1 review available for sulfinpyrazone and Rheumatic Heart Disease
| Article | Year |
|---|---|
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Dis | 1971 |
1 trial available for sulfinpyrazone and Rheumatic Heart Disease
| Article | Year |
|---|---|
Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
Topics: Adult; Blood Platelets; Cell Survival; Clinical Trials as Topic; Combined Modality Therapy; Double-B | 1983 |
4 other studies available for sulfinpyrazone and Rheumatic Heart Disease
| Article | Year |
|---|---|
Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Cell Survival; Disseminated Intravascular Coagula | 1981 |
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
Topics: Atrial Fibrillation; Blood Coagulation; Blood Platelets; Cell Survival; Heart Valve Prosthesis; Huma | 1980 |
Platelet survival time and thromboembolism in patients with mitral valve prolapse.
Topics: Adult; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Chromium Radioisotopes; Female; Hu | 1979 |
Platelet survival in patients with rheumatic heart disease.
Topics: Adenosine Diphosphate; Aortic Valve Stenosis; Blood Platelets; Cell Survival; Chromium Radioisotopes | 1974 |